LRR5 (PF3D7_1432400) is a Plasmodium falciparum leucine-rich repeat protein that couples protein phosphatase type 1 (PP1) regulation to developmental timing and host-cell remodeling during the intraerythrocytic cycle (PMID:16629662, PMID:42294623). It is the P. falciparum SDS22 orthologue and physically associates with PfPP1, inhibiting the phosphatase in vitro; in a heterologous Xenopus oocyte system it drives progression through the G2/M checkpoint and germinal vesicle breakdown in a manner mimicking PP1 inhibition, linking LRR5 to cell-cycle control (PMID:16629662). Loss-of-function analysis in P. falciparum shows that disruption of LRR5 downregulates protein folding, protein export, and host-cell remodeling machinery (Maurer's cleft components, the PTEX export apparatus, and HSP70-x) while upregulating cytoplasmic heat-shock and translation genes, and prematurely activates gametocyte-associated programs including elevated Pfs16, indicating LRR5 restrains developmental progression toward transmission (PMID:42294623). The P. berghei orthologue PbLRR1 similarly forms a stage-spanning complex with PbPP1 and controls the phosphorylation status of Inhibitor 3, and its depletion impairs oocyst development (PMID:35920043). Beyond the PP1 interaction and these transcriptional and cell-cycle phenotypes, no substrate specificity or structural mechanism for LRR5 itself has been characterized in the available corpus.